Please Wait
Applying Filters...
menu
    • menu
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-03

    Virtual Booth

    An Enquiry

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Levocloperastine Fendizoate

    ACTIVE PHARMA INGREDIENTS

    MARKET PLACE

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,133Xls

    Filters

    clear-filterReset all filters
    2D Structure
    Also known as: 220329-19-1, Privituss, (s)-cloperastine fendizoate, 09837k287s, 1-[2-[(s)-(4-chlorophenyl)-phenylmethoxy]ethyl]piperidine;2-(4-hydroxy-3-phenylbenzoyl)benzoic acid, Benzoic acid, 2-((6-hydroxy(1,1'-biphenyl)-3-yl)carbonyl)-, compd. with (-)-1-(2-((4-chlorophenyl)phenylmethoxy)ethyl)piperidine (1:1)
    Molecular Formula
    C40H38ClNO5
    Molecular Weight
    648.2  g/mol
    InChI Key
    PXZFKAKWSHBDCP-BDQAORGHSA-N
    FDA UNII
    09837K287S
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    1-[2-[(S)-(4-chlorophenyl)-phenylmethoxy]ethyl]piperidine;2-(4-hydroxy-3-phenylbenzoyl)benzoic acid
    2.1.2 InChI
    InChI=1S/C20H24ClNO.C20H14O4/c21-19-11-9-18(10-12-19)20(17-7-3-1-4-8-17)23-16-15-22-13-5-2-6-14-22;21-18-11-10-14(12-17(18)13-6-2-1-3-7-13)19(22)15-8-4-5-9-16(15)20(23)24/h1,3-4,7-12,20H,2,5-6,13-16H2;1-12,21H,(H,23,24)/t20-;/m0./s1
    2.1.3 InChI Key
    PXZFKAKWSHBDCP-BDQAORGHSA-N
    2.1.4 Canonical SMILES
    C1CCN(CC1)CCOC(C2=CC=CC=C2)C3=CC=C(C=C3)Cl.C1=CC=C(C=C1)C2=C(C=CC(=C2)C(=O)C3=CC=CC=C3C(=O)O)O
    2.1.5 Isomeric SMILES
    C1CCN(CC1)CCO[C@@H](C2=CC=CC=C2)C3=CC=C(C=C3)Cl.C1=CC=C(C=C1)C2=C(C=CC(=C2)C(=O)C3=CC=CC=C3C(=O)O)O
    2.2 Other Identifiers
    2.2.1 UNII
    09837K287S
    2.3 Synonyms
    2.3.1 Depositor-Supplied Synonyms

    1. 220329-19-1

    2. Privituss

    3. (s)-cloperastine Fendizoate

    4. 09837k287s

    5. 1-[2-[(s)-(4-chlorophenyl)-phenylmethoxy]ethyl]piperidine;2-(4-hydroxy-3-phenylbenzoyl)benzoic Acid

    6. Benzoic Acid, 2-((6-hydroxy(1,1'-biphenyl)-3-yl)carbonyl)-, Compd. With (-)-1-(2-((4-chlorophenyl)phenylmethoxy)ethyl)piperidine (1:1)

    7. Benzoic Acid, 2-((6-hydroxy(1,1'-biphenyl)-3-yl)carbonyl)-, Compd. With 1-(2-((s)-(4-chlorophenyl)phenylmethoxy)ethyl)piperidine (1:1)

    8. Piperidine, 1-(2-((4-chlorophenyl)phenylmethoxy)ethyl)-, (-)-, 2-((6-hydroxy(1,1'-biphenyl)-3-yl)carbonyl)benzoate

    9. Unii-09837k287s

    10. Levocloperastine Fendizoate [who-dd]

    11. Q27236467

    2.4 Create Date
    2015-03-18
    3 Chemical and Physical Properties
    Molecular Weight 648.2 g/mol
    Molecular Formula C40H38ClNO5
    Hydrogen Bond Donor Count2
    Hydrogen Bond Acceptor Count6
    Rotatable Bond Count10
    Exact Mass647.2438510 g/mol
    Monoisotopic Mass647.2438510 g/mol
    Topological Polar Surface Area87.1 Ų
    Heavy Atom Count47
    Formal Charge0
    Complexity772
    Isotope Atom Count0
    Defined Atom Stereocenter Count1
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count2